Sign in

    Alejandro Zamacona Urquiza • HSBC

    Alejandro Zamacona Urquiza's questions to Auna SA (AUNA) leadership

    Alejandro Zamacona Urquiza's questions to Auna SA (AUNA) leadership • Q4 2024

    Question

    Alejandro Zamacona Urquiza asked for details on the Opcion Oncologia agreement, including the expected volume transfer and margin outlook, and inquired about the strategy for phasing out services to Nueva EPS in Colombia.

    Answer

    Executive Chairman and President Suso Zamora stated the Opcion Oncologia deal is expected to channel its 30% market share, plus significant spillover volume, to Auna over time, but did not disclose specific margins. Regarding Nueva EPS, he described the current stance as limiting services to pressure the payer, but noted recent dialogue has improved and expects a more normalized relationship by year-end.

    Ask Fintool Equity Research AI

    Alejandro Zamacona Urquiza's questions to Auna SA (AUNA) leadership • Q3 2024

    Question

    Alejandro Zamacona Urquiza asked for any early expectations for 2025 and for an update on the OncoMexico insurance plan rollout, specifically how it's performing against initial expectations and what is coming next.

    Answer

    Jesús Zamora Leon, Executive Chairman and President, declined to give 2025 guidance but detailed the OncoMexico pilot. He explained it is performing well, confirming a market need and strong product appeal, especially in the B2B segment and among specific B2C demographics like working women and independent professionals. The strategy is to first build B2B relationships before a broader B2C rollout.

    Ask Fintool Equity Research AI